Clinical trial
Metabolic Pathways of GRA in Patients With Type 1 Diabetes
NCT03919617
Study timeline
Study start (actual)2019-07-01Date precision: day
Registry last updated2022-07-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 1 Diabetes Mellitusunresolved
Interventions
REMD-477DRUG
Sponsors & collaborators
University of California, San Diegolead sponsor
REMD Biotherapeutics, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03919617 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.